Critical Wavelength Should Be Compared To In Vitro Method, P&G Says
This article was originally published in The Rose Sheet
Executive Summary
The critical wavelength method of determining a sunscreen's percentage of UVA absorption should be compared to an in vitro SPF, not an in vivo SPF, Procter & Gamble maintains in Nov. 10 comments to FDA.
You may also be interested in...
Half Of Broad Spectrum Sunscreens Lack UVA Protection – P&G Study
Over half of sunscreens marketed in the U.S. claiming to provide UVA protection do not contain long wavelength UVA-I filters, according to Procter & Gamble
Half Of Broad Spectrum Sunscreens Lack UVA Protection – P&G Study
Over half of sunscreens marketed in the U.S. claiming to provide UVA protection do not contain long wavelength UVA-I filters, according to Procter & Gamble
L'Oreal Critical Wavelength Criticism Based On "Flawed" Analysis - P&G
L'Oreal used a "flawed technical analysis" in assessing the critical wavelength method as a UVA sunscreen testing assay, Procter & Gamble asserts in May 2 comments to FDA.